Combination Therapy for MPN Patients

Dr. Ruben Mesa, deputy director at Mayo Clinic Cancer Center, provides an update on where we stand with single agents and combination therapy to treat MPNs. Dr. Mesa details current and developing therapies and what they might mean for some MPN patients. Dr. Mesa discusses the broad spectrum of ongoing clinical trials for MPNs and is hopeful that research he and his colleagues are leading will help to yield more effective treatments that extend survival.